Luciferase Units/β-gal | |||
---|---|---|---|
Cell Line | Basal | Ciglitazone | Sulindac Sulfide |
Neo | 6,617 ± 1,493 | 11,246 ± 3,256 | 10,242 ± 1,591 |
PPARγ-16 | 20,236 ± 1,056 | 99,747 ± 7,400 | 53,879 ± 4,097 |
PPARγ-18 | 58,805 ± 4,778 | 258,823 ± 3,4120 | 136,556 ± 3,516 |
PPARγ-3 | 54,517 ± 3,608 | 91484 ± 31,348 | 99,902 ± 19,766 |
H2122 cells were stably transfected with retroviruses encoding full-length PPARγ and individual clones were selected for resistance to G-418. Control cells (Neo) were transfected with a retroviral vector lacking an insert. Three clones overexpressing PPARγ and one Neo clone were transiently transfected with the PPAR-RE promoter construct as described in Fig. 2. Cells were stimulated for 24 h with either 10 μ M ciglitazone or 25 μ M sulindac sulfide, and promoter activity normalized to β -gal was determined. Results represent the mean of three independent experiments.